United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
456.84
+3.56 (0.79%)
At close: Oct 7, 2025, 4:00 PM EDT
454.05
-2.79 (-0.61%)
After-hours: Oct 7, 2025, 7:58 PM EDT
United Therapeutics Employees
United Therapeutics had 1,305 employees as of December 31, 2024. The number of employees increased by 137 or 11.73% compared to the previous year.
Employees
1,305
Change (1Y)
137
Growth (1Y)
11.73%
Revenue / Employee
$2,358,467
Profits / Employee
$951,801
Market Cap
20.66B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,305 | 137 | 11.73% |
Dec 31, 2023 | 1,168 | 183 | 18.58% |
Dec 31, 2022 | 985 | 20 | 2.07% |
Dec 31, 2021 | 965 | 15 | 1.58% |
Dec 31, 2020 | 950 | 30 | 3.26% |
Dec 31, 2019 | 920 | 60 | 6.98% |
Dec 31, 2018 | 860 | 60 | 7.50% |
Dec 31, 2017 | 800 | 50 | 6.67% |
Dec 31, 2016 | 750 | 0 | - |
Dec 31, 2015 | 750 | 10 | 1.35% |
Dec 31, 2014 | 740 | 34 | 4.82% |
Dec 31, 2013 | 706 | 83 | 13.32% |
Dec 31, 2012 | 623 | 80 | 14.73% |
Dec 31, 2011 | 543 | 23 | 4.42% |
Dec 31, 2010 | 520 | 110 | 26.83% |
Dec 31, 2009 | 410 | 50 | 13.89% |
Dec 31, 2008 | 360 | 40 | 12.50% |
Dec 31, 2007 | 320 | 35 | 12.28% |
Dec 31, 2006 | 285 | 75 | 35.71% |
Dec 31, 2005 | 210 | 40 | 23.53% |
Dec 31, 2004 | 170 | 10 | 6.25% |
Dec 31, 2003 | 160 | 10 | 6.67% |
Dec 31, 2002 | 150 | 22 | 17.19% |
Dec 31, 2001 | 128 | 18 | 16.36% |
Dec 31, 2000 | 110 | 47 | 74.60% |
Dec 31, 1999 | 63 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
UTHR News
- 9 days ago - United Therapeutics Corporation - Special Call - Seeking Alpha
- 14 days ago - United Therapeutics Corporation (UTHR) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 18 days ago - United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary Fibrosis - Business Wire
- 21 days ago - United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum - Business Wire
- 25 days ago - United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the European Respiratory Society Congress - Business Wire
- 4 weeks ago - United Therapeutics Corporation (UTHR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 4 weeks ago - United Therapeutics: Nebulized Tyvaso Label Expansion Possible For IPF After Study Win - Seeking Alpha
- 4 weeks ago - United Therapeutics: Is UTHR Stock Still A Buy At $400? - Forbes